Literature DB >> 6732652

Inhibition of stomal recurrence in laryngectomy with preoperative far therapy. A statistical evaluation.

S Komiyama, H Watanabe, T Yanagita, M Kuwano, I Hiroto.   

Abstract

FAR therapy is effective for cancers of the head and neck, in particular laryngeal cancer. This combined chemoradiotherapy consists of 5-FU, vitamin A and radiation. We found 10% stomal recurrences in reviewing 112 patients who had been treated with total laryngectomy. Stomal recurrences after total laryngectomy occur frequently in patients undergoing an emergency tracheotomy. We studied 33 such patients divided into 2 groups, on the basis of whether laryngectomy had been carried out after the emergency tracheotomy plus preoperative FAR therapy, or whether laryngectomy had been carried out without preoperative FAR therapy. The incidence of stomal recurrence was less among those given preoperative FAR therapy and was statistically significant. Such being the case, preoperative FAR therapy seems to e prophylactically effective against stomal recurrence after emergency tracheotomy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732652     DOI: 10.1016/s0385-8146(84)80017-6

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil.

Authors:  Muneyuki Masuda; Satoshi Toh; Koji Koike; Yuichiro Kuratomi; Masumi Suzui; Atsuko Deguchi; Sohtaro Komiyama; I Bernard Weinstein
Journal:  Jpn J Cancer Res       Date:  2002-03

Review 2.  Which risk factors are associated with stomal recurrence after total laryngectomy for laryngeal cancer? A meta-analysis of the last 30 years.

Authors:  Jiwang Liang; Xiangyu Zhu; Wei Zeng; Tao Yu; Fengqin Fang; Yuejiao Zhao
Journal:  Braz J Otorhinolaryngol       Date:  2020-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.